The nephrologist's anticoagulation treatment patterns/regimens in chronic hemodialysis patients with atrial fibrillation

Journal of Nephrology

Volumn 27, Issue 2, 2014, Pages 187-192

  Genovesi, Simonetta ^a,b   Rossi, Emanuela ^a   Pogliani, Daniela ^a   Gallieni, Maurizio ^c   Stella, Andrea ^a,b   Badiali, Fabio ^d   Conte, Ferruccio ^e   Pasquali, Sonia ^f   Bertoli, Silvio ^g   Ondei, Patrizia ^h   Bonforte, Giuseppe ⁱ   Pozzi, Claudio ^j   Valsecchi, Maria Grazia ^a   Santoro, Antonio ^k  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c SAN CARLO BORROMEO HOSPITAL   (Italy)

^d Infermi Hospital   (Italy)

^e Nephrology Unit S Uboldo Hospital   (Italy)

^f S MARIA NUOVA HOSPITAL   (Italy)

^g IRCCS MULTIMEDICA   (Italy)

^h OSPEDALI RIUNITI   (Italy)

ⁱ SANT ANNA HOSPITAL   (Italy)

^j Ospedale Bassini di Cinisello Balsamo Divisione Medicina   (Italy)

^k UNIVERSITY OF BOLOGNA   (Italy)

more..

Author keywords

Atrial fibrillation; Bleeding; Hemodialysis; Oral anticoagulant therapy; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE; WARFARIN;

AGED; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CHADS2 SCORE; ECHOCARDIOGRAPHY; FEMALE; HASBLED SCORE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEMODIALYSIS; HUMAN; HYPERTENSION; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NEPHROLOGIST; PRESCRIPTION; QUESTIONNAIRE; SCORING SYSTEM; THROMBOEMBOLISM; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COMPLICATION; NEPHROLOGY; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; NEPHROLOGY; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; STROKE; THROMBOEMBOLISM;

EID: 84901022284     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-013-0030-3     Document Type: Article

References (30)

1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946-952
2. Lévy S, Maarek M, Coumel P et al (1999) Characterization of different subsets of atrial fibrillation in general practice in France. Circulation 99:3028-3035
3. Lip GY (2011) Stroke in atrial fibrillation: epidemiology and thromboprophylaxis. J Thromb Haemost 9:344-351
4. Camm AJ, Lip GYH, De Caterina R et al (2012) An update of the 2010 ESC Guidelines for the management of atrial fibrillation developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33(21):2719-2747
5. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation-Executive Summary (2001) A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the Guidelines for the Management of Patients with Atrial Fibrillation). Circulation 2006(114):700-752
6. Camm AJ, Kirchhof P, Lip GY et al (2010) ESC Committee for Practice Guidelines, Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 12:1360-1420
7. Vazquez E, Sanchez-Perales C, Borrego F et al (2000) Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J 140:886-890
8. Genovesi S, Pogliani D, Faini A et al (2005) Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients. Am J Kidney Dis 46:897-902
9. Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S (2011) The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 22:349-357
10. Seliger SL, Gillen DL, Longstreth WT, Kestenbaum B, Stehman-Breen CO (2003) Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 64:603-609
11. Genovesi S, Vincenti A, Rossi E et al (2008) Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 2:255-262
12. Sanchez-Perales C, Vazquez E, Garcia-Cortes MJ et al (2010) Ischaemic stroke in incident dialysis patients. Nephrol Dial Transplant 25:3343-3348
13. Olesen JB, Lip GYH, Kamper AL et al (2012) Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 367:625-635
14. Boccardo P, Remuzzi G, Galbusera M (2004) Platelet dysfunction in renal failure. Semin Thromb Hemost 30:579-589
15. Elliott MJ, Zimmerman D, Holden RM (2007) Warfarin anticoagulation in hemodialysis patient: a systemic review of bleeding rates. Am J Kidney Dis 50:433-440
16. Chan KE, Lazarus M, Thadhani R, Hakim RM (2009) Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 20:2223-2233
17. Wizemann V, Tong L, Statayathum S et al (2010) Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy. Kidney Int 77:1098-1106
18. Winkelmayer WC, Liu J, Setoguchi S, Choudhry NK (2011) Effectiveness and safety of Warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol 6:2662-2668
19. Danziger J (2008) Vitamin K-dependent proteins, warfarin, and vascular calcification. Clin J Am Soc Nephrol. 3:1504-1510
20. Di Pasquale G, Mathieu G, Maggioni AP et al (2012) Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATAAF study. Int J Cardiol (in press)
21. Turakhia MP, Hoang DD, Xu X et al (2013) Differences and trends in stroke prevention anticoagulation in primary care vs. cardiology specialty management of new atrial fibrillation: the retrospective Evaluation and assessment of therapies in AF (TREAT-AF) study. Am Heart J 165:93-101
22. Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE (1999) Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med 131:927-934
23. Monte S, Macchia A, Pellegrini F et al (2006) Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation. Eur Heart J 27:2217-2223
24. Zimetbaum PJ, Thosani A, Yu HT et al (2010) Are atrial fibrillation patients receiving warfarin in accordance with stroke risk? Am J Med 123:446-453
25. Nieuwlaat R, Capucci A, Lip GY et al (2006) Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on atrial fibrillation. Eur Heart J 27:3018-3026
26. Winkelmayer WC, Liu J, Patrick AR, Setoguchi S, Choudhry NK (2012) Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis. J Nephrol 25:341-353
27. Waldo AL, Becker RC, Tapson VF, Colgan KJ (2005) Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 46:1729-1736
28. Flaker GC, Belew K, Beckman K et al (2005) AFFIRM investigators: asymptomatic atrial fibrillation: demographic features and prognostic information from the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Am Heart J 149:657-663
29. Friberg L, Hammar N, Rosenqvist M (2010) Stroke in paroxysmal atrial fibrillation: report from the Stockholm cohort of atrial fibrillation. Eur Heart J 31:967-975
30. Chou CY, Kuo HL, Wang SM et al (2010) Outcome of atrial fibrillation among patients with end-stage renal disease. Nephrol Dial Transplant 25:1225-1230